{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:52:42Z","timestamp":1793659962884,"version":"4.5.1"},"reference-count":119,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T00:00:00Z","timestamp":1726704000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["TMSGI3_21848 8"],"award-info":[{"award-number":["TMSGI3_21848 8"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["310030_219673"],"award-info":[{"award-number":["310030_219673"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023177","name":"Pierre Mercier Foundation for Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023177","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013850","name":"Helmut Horten Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013850","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cell Biology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.tcb.2024.09.001","type":"journal-article","created":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T08:13:47Z","timestamp":1727856827000},"page":"399-411","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Senescent neutrophils: a hidden role in cancer progression"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8862-961X","authenticated-orcid":false,"given":"Ryan N.","family":"Rys","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1746-6424","authenticated-orcid":false,"given":"Arianna","family":"Calcinotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tcb.2024.09.001_bb0005","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.4049\/jimmunol.172.5.2731","article-title":"Of mice and not men: differences between mouse and human immunology","volume":"172","author":"Mestas","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.tcb.2024.09.001_bb0010","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.immuni.2021.06.006","article-title":"The neutrophil","volume":"54","author":"Burn","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.tcb.2024.09.001_bb0015","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.it.2019.04.013","article-title":"The Neutrophil life cycle","volume":"40","author":"Hidalgo","year":"2019","journal-title":"Trends Immunol."},{"key":"10.1016\/j.tcb.2024.09.001_bb0020","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.immuni.2019.01.002","article-title":"A neutrophil timer coordinates immune defense and vascular protection","volume":"50","author":"Adrover","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.tcb.2024.09.001_bb0025","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41590-017-0022-x","article-title":"Myeloid-derived suppressor cells coming of age","volume":"19","author":"Veglia","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.tcb.2024.09.001_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2021.101546","article-title":"Impact of cancer cell-intrinsic features on neutrophil behavior","volume":"57","author":"Duits","year":"2021","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.tcb.2024.09.001_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.20220011","article-title":"Neutrophil phenotypes and functions in cancer: a consensus statement","volume":"219","author":"Quail","year":"2022","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tcb.2024.09.001_bb0040","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-56218-z","article-title":"Exploring the prognostic value of the neutrophil-to-lymphocyte ratio in cancer","volume":"9","author":"Howard","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tcb.2024.09.001_bb0045","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-75745-8","article-title":"Neutrophil to lymphocyte ratio predicts prognosis in unresectable pancreatic cancer","volume":"10","author":"Iwai","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tcb.2024.09.001_bb0050","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/s41467-021-20935-9","article-title":"Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors","volume":"12","author":"Valero","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tcb.2024.09.001_bb0055","doi-asserted-by":"crossref","DOI":"10.1177\/17588359231193732","article-title":"Low neutrophil-to-lymphocyte ratio and pan-immune-inflammation-value predict nodal pathologic complete response in 1274 breast cancer patients treated with neoadjuvant chemotherapy: a multicenter analysis","volume":"15","author":"Gasparri","year":"2023","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.tcb.2024.09.001_bb0060","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/nm.3909","article-title":"The prognostic landscape of genes and infiltrating immune cells across human cancers","volume":"21","author":"Gentles","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.tcb.2024.09.001_bb0065","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41577-019-0141-8","article-title":"Heterogeneity of neutrophils","volume":"19","author":"Ng","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.tcb.2024.09.001_bb0070","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.it.2019.05.004","article-title":"Granulopoiesis and neutrophil homeostasis: a metabolic, daily balancing act","volume":"40","author":"Yvan-Charvet","year":"2019","journal-title":"Trends Immunol."},{"key":"10.1016\/j.tcb.2024.09.001_bb0075","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nature14282","article-title":"IL-17-producing \u03b3\u03b4 T cells and neutrophils conspire to promote breast cancer metastasis","volume":"522","author":"Coffelt","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.tcb.2024.09.001_bb0080","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41577-021-00571-6","article-title":"Neutrophils in cancer: heterogeneous and multifaceted","volume":"22","author":"Hedrick","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.tcb.2024.09.001_bb0085","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nrc.2016.54","article-title":"The role of myeloid cells in cancer therapies","volume":"16","author":"Engblom","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.tcb.2024.09.001_bb0090","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.ccell.2017.11.004","article-title":"Myeloid cell-derived reactive oxygen species induce epithelial mutagenesis","volume":"32","author":"Canli","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tcb.2024.09.001_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101277","article-title":"Early neutrophil responses to chemical carcinogenesis shape long-term lung cancer susceptibility","volume":"23","author":"Wculek","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.tcb.2024.09.001_bb0100","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1172\/JCI122085","article-title":"Neutrophil-induced genomic instability impedes resolution of inflammation and wound healing","volume":"129","author":"Butin-Israeli","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tcb.2024.09.001_bb0105","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41420-020-0255-6","article-title":"The role of neutrophil death in chronic inflammation and cancer","volume":"6","author":"Brostjan","year":"2020","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.tcb.2024.09.001_bb0110","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.15252\/embj.201490147","article-title":"The wound inflammatory response exacerbates growth of pre-neoplastic cells and progression to cancer","volume":"34","author":"Antonio","year":"2015","journal-title":"EMBO J."},{"key":"10.1016\/j.tcb.2024.09.001_bb0115","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/nature13638","article-title":"Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer","volume":"515","author":"Di Mitri","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.tcb.2024.09.001_bb0120","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nm.2084","article-title":"Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth","volume":"16","author":"Houghton","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.tcb.2024.09.001_bb0125","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ccell.2019.08.003","article-title":"Epithelial NOTCH signaling rewires the tumor microenvironment of colorectal cancer to drive poor-prognosis subtypes and metastasis","volume":"36","author":"Jackstadt","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tcb.2024.09.001_bb0130","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s13046-015-0256-0","article-title":"Peritumoural neutrophils negatively regulate adaptive immunity via the PD-L1\/PD-1 signalling pathway in hepatocellular carcinoma","volume":"34","author":"He","year":"2015","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.tcb.2024.09.001_bb0135","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1136\/gutjnl-2016-313075","article-title":"Tumour-activated neutrophils in gastric cancer foster immune suppression and disease progression through GM-CSF-PD-L1 pathway","volume":"66","author":"Wang","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.tcb.2024.09.001_bb0140","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1158\/2326-6066.CIR-18-0489","article-title":"Immune-checkpoint protein Vista regulates antitumor immunity by controlling myeloid cell-mediated inflammation and immunosuppression","volume":"7","author":"Xu","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.tcb.2024.09.001_bb0145","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/s43018-023-00594-z","article-title":"The Akt\/MTOR and MNK\/EIF4E pathways rewire the prostate cancer translatome to secrete HGF, SPP1 and BGN and recruit suppressive myeloid cells","volume":"4","author":"Brina","year":"2023","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.tcb.2024.09.001_bb0150","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41586-018-0266-0","article-title":"IL-23 secreted by myeloid cells drives castration-resistant prostate cancer","volume":"559","author":"Calcinotto","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.tcb.2024.09.001_bb0155","doi-asserted-by":"crossref","first-page":"12493","DOI":"10.1073\/pnas.0601807103","article-title":"Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis","volume":"103","author":"Nozawa","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.tcb.2024.09.001_bb0160","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/nature06348","article-title":"Bv8 regulates myeloid-cell-dependent tumour angiogenesis","volume":"450","author":"Shojaei","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.tcb.2024.09.001_bb0165","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.ajpath.2011.05.031","article-title":"Tumor-recruited neutrophils and neutrophil TIMP-free MMP-9 regulate coordinately the levels of tumor angiogenesis and efficiency of malignant cell intravasation","volume":"179","author":"Bekes","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.tcb.2024.09.001_bb0170","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/s41586-019-0915-y","article-title":"Neutrophils escort circulating tumour cells to enable cell cycle progression","volume":"566","author":"Szczerba","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.tcb.2024.09.001_bb0175","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nature16140","article-title":"Neutrophils support lung colonization of metastasis-initiating breast cancer Cells","volume":"528","author":"Wculek","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.tcb.2024.09.001_bb0180","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1158\/1078-0432.CCR-20-1319","article-title":"IL8, neutrophils, and NETs in a collusion against cancer immunity and immunotherapy","volume":"27","author":"Teijeira","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tcb.2024.09.001_bb0185","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.3389\/fimmu.2020.01749","article-title":"The emerging role of neutrophil extracellular traps (NETs) in tumor progression and metastasis","volume":"11","author":"Masucci","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tcb.2024.09.001_bb0190","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ccell.2020.12.012","article-title":"Cathepsin C promotes breast cancer lung metastasis by modulating neutrophil infiltration and neutrophil extracellular trap formation","volume":"39","author":"Xiao","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tcb.2024.09.001_bb0195","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12341","article-title":"Tumour extracellular vesicles induce neutrophil extracellular traps to promote lymph node metastasis","volume":"12","author":"Su","year":"2023","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.tcb.2024.09.001_bb0200","doi-asserted-by":"crossref","first-page":"5443","DOI":"10.1111\/jcmm.16555","article-title":"Neutrophil extracellular DNA traps promote pancreatic cancer cells migration and invasion by activating EGFR\/ERK pathway","volume":"25","author":"Jin","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.tcb.2024.09.001_bb0205","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ccell.2023.02.001","article-title":"NETworking with cancer: the bidirectional interplay between cancer and neutrophil extracellular traps","volume":"41","author":"Adrover","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tcb.2024.09.001_bb0210","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41586-020-2394-6","article-title":"DNA of neutrophil extracellular traps promotes cancer metastasis via CCDC25","volume":"583","author":"Yang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.tcb.2024.09.001_bb0215","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1158\/0008-5472.CAN-03-1808","article-title":"Neutrophil-derived TNF-related apoptosis-inducing ligand (TRAIL): a novel mechanism of antitumor effect by neutrophils","volume":"64","author":"Koga","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.tcb.2024.09.001_bb0220","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nature14407","article-title":"MET is required for the recruitment of anti-tumoural neutrophils","volume":"522","author":"Finisguerra","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.tcb.2024.09.001_bb0225","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1016\/j.cell.2021.04.016","article-title":"Neutrophil elastase selectively kills cancer cells and attenuates tumorigenesis","volume":"184","author":"Cui","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.tcb.2024.09.001_bb0230","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.3390\/cancers13174261","article-title":"CD47-SIRP\u03b1 checkpoint inhibition enhances neutrophil-mediated killing of dinutuximab-opsonized neuroblastoma cells","volume":"13","author":"Mart\u00ednez-Sanz","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.tcb.2024.09.001_bb0235","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1158\/2326-6066.CIR-20-0491","article-title":"Kindlin3-dependent CD11b\/CD18\u2013integrin activation is required for potentiation of neutrophil cytotoxicity by CD47\u2013SIRPa checkpoint disruption","volume":"9","author":"Bouti","year":"2021","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.tcb.2024.09.001_bb0240","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.cell.2023.03.007","article-title":"T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variants","volume":"186","author":"Hirschhorn","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.tcb.2024.09.001_bb0245","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ccell.2023.01.002","article-title":"Neutrophil-activating therapy for the treatment of cancer","volume":"41","author":"Linde","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tcb.2024.09.001_bb0250","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1172\/JCI77053","article-title":"Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer","volume":"124","author":"Eruslanov","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tcb.2024.09.001_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111171","article-title":"During early stages of cancer, neutrophils initiate anti-tumor immune responses in tumor-draining lymph nodes","volume":"40","author":"Pylaeva","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.tcb.2024.09.001_bb0260","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.cell.2019.05.047","article-title":"Neutrophils driving unconventional T cells mediate resistance against murine sarcomas and selected human tumors","volume":"178","author":"Ponzetta","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.tcb.2024.09.001_bb0265","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.cell.2024.02.005","article-title":"Neutrophil profiling illuminates anti-tumor antigen-presenting potency","volume":"187","author":"Wu","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.tcb.2024.09.001_bb0270","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nri3660","article-title":"Emergency granulopoiesis","volume":"14","author":"Manz","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.tcb.2024.09.001_bb0275","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41568-020-0281-y","article-title":"Neutrophil diversity and plasticity in tumour progression and therapy","volume":"20","author":"Jaillon","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.tcb.2024.09.001_bb0280","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ccr.2009.06.017","article-title":"Polarization of tumor-associated neutrophil phenotype by TGF-\u03b2: 'N1' versus 'N2' TAN","volume":"16","author":"Fridlender","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tcb.2024.09.001_bb0285","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41586-022-05400-x","article-title":"Liver tumour immune microenvironment subtypes and neutrophil heterogeneity","volume":"612","author":"Xue","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.tcb.2024.09.001_bb0290","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.immuni.2019.03.009","article-title":"Single-cell transcriptomics of human and mouse lung cancers reveals conserved myeloid populations across individuals and species","volume":"50","author":"Zilionis","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.tcb.2024.09.001_bb0295","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000473","article-title":"CyTOF mass cytometry reveals phenotypically distinct human blood neutrophil populations differentially correlated with melanoma stage","volume":"8","author":"Zhu","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.tcb.2024.09.001_bb0300","doi-asserted-by":"crossref","DOI":"10.1126\/science.adf6493","article-title":"Deterministic reprogramming of neutrophils within tumors","volume":"383","author":"Ng","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.tcb.2024.09.001_bb0305","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.immuni.2020.07.017","article-title":"Coexpression of CD71 and CD117 identifies an early unipotent neutrophil progenitor population in human bone marrow","volume":"53","author":"Dinh","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.tcb.2024.09.001_bb0310","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.immuni.2020.06.005","article-title":"Combinatorial single-cell analyses of granulocyte-monocyte progenitor heterogeneity reveals an early uni-potent neutrophil progenitor","volume":"53","author":"Kwok","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.tcb.2024.09.001_bb0315","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.celrep.2018.07.097","article-title":"Identification of an early unipotent neutrophil progenitor with pro-tumoral activity in mouse and human bone marrow","volume":"24","author":"Zhu","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.tcb.2024.09.001_bb0320","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/s41590-020-0736-z","article-title":"Single-cell transcriptome profiling reveals neutrophil heterogeneity in homeostasis and infection","volume":"21","author":"Xie","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.tcb.2024.09.001_bb0325","article-title":"Osteoblasts remotely supply lung tumors with cancer-promoting siglecfhigh neutrophils","volume":"358","author":"Engblom","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.tcb.2024.09.001_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108164","article-title":"Tumor-promoting Ly-6G+ SiglecFhigh cells are mature and long-lived neutrophils","volume":"32","author":"Pfirschke","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.tcb.2024.09.001_bb0335","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s44321-023-00013-x","article-title":"Bcl-XL targeting eliminates ageing tumor-promoting neutrophils and inhibits lung tumor growth","volume":"16","author":"Bodac","year":"2024","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.tcb.2024.09.001_bb0340","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1152\/physrev.00020.2018","article-title":"Cellular senescence: aging, cancer, and injury","volume":"99","author":"Calcinotto","year":"2019","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.tcb.2024.09.001_bb0345","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cell.2007.07.003","article-title":"Cellular senescence in cancer and aging","volume":"130","author":"Collado","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.tcb.2024.09.001_bb0350","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1172\/JCI95148","article-title":"Mechanisms and functions of cellular senescence","volume":"128","author":"Herranz","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tcb.2024.09.001_bb0355","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-29824-1","article-title":"Single-cell transcriptomics identifies Mcl-1 as a target for senolytic therapy in cancer","volume":"13","author":"Troiani","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tcb.2024.09.001_bb0360","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41574-020-0335-y","article-title":"The role of cellular senescence in ageing and endocrine disease","volume":"16","author":"Khosla","year":"2020","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.tcb.2024.09.001_bb0365","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41568-019-0156-2","article-title":"Unmasking senescence: context-dependent effects of SASP in cancer","volume":"19","author":"Faget","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.tcb.2024.09.001_bb0370","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1146\/annurev-pathol-121808-102144","article-title":"The senescence-associated secretory phenotype: the dark side of tumor suppression","volume":"5","author":"Copp\u00e9","year":"2010","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.tcb.2024.09.001_bb0375","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1093\/jnci\/djq364","article-title":"Therapy-induced senescence in cancer","volume":"102","author":"Ewald","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.tcb.2024.09.001_bb0380","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ccell.2020.10.012","article-title":"Senescence reprogramming by TIMP1 deficiency promotes prostate cancer metastasis","volume":"39","author":"Guccini","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tcb.2024.09.001_bb0385","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1158\/2159-8290.CD-16-0241","article-title":"Cellular senescence promotes adverse effects of chemotherapy and cancer relapse","volume":"7","author":"Demaria","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.tcb.2024.09.001_bb0390","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/s41416-022-01787-6","article-title":"Considering therapy-induced senescence as a mechanism of tumour dormancy contributing to disease recurrence","volume":"126","author":"Saleh","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.tcb.2024.09.001_bb0395","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1038\/s41388-022-02433-4","article-title":"Therapy-induced senescence promotes breast cancer cells plasticity by inducing lipocalin-2 expression","volume":"41","author":"Morales-Valencia","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.tcb.2024.09.001_bb0400","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/s43018-023-00712-x","article-title":"The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2","volume":"5","author":"Chaib","year":"2024","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.tcb.2024.09.001_bb0405","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1038\/s41467-024-46769-9","article-title":"Senescence drives immunotherapy resistance by inducing an immunosuppressive tumor microenvironment","volume":"15","author":"Maggiorani","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tcb.2024.09.001_bb0410","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1089\/ars.2020.8048","article-title":"Senescence in post-mitotic cells: a driver of aging?","volume":"34","author":"von Zglinicki","year":"2020","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.tcb.2024.09.001_bb0415","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.1038\/s41467-022-33226-8","article-title":"Rejuvenation of the aged brain immune cell landscape in mice through p16-positive senescent cell clearance","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tcb.2024.09.001_bb0420","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1182\/blood-2010-10-313106","article-title":"P16INK4a deficiency promotes IL-4-induced polarization and inhibits proinflammatory signaling in macrophages","volume":"118","author":"Cudejko","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.tcb.2024.09.001_bb0425","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1007\/s00125-011-2324-0","article-title":"Downregulation of the tumour suppressor P16 INK4A contributes to the polarisation of human macrophages toward an adipose tissue macrophage (ATM)-like phenotype","volume":"54","author":"Fuentes","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.tcb.2024.09.001_bb0430","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.18632\/aging.101268","article-title":"P16(Ink4a) and senescence-associated \u03b2-galactosidase can be induced in macrophages as part of a reversible response to physiological stimuli","volume":"9","author":"Hall","year":"2017","journal-title":"Aging (Albany. NY)"},{"key":"10.1016\/j.tcb.2024.09.001_bb0435","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1016\/j.immuni.2023.11.011","article-title":"Circulating senescent myeloid cells infiltrate the brain and cause neurodegeneration in histiocytic disorders","volume":"56","author":"Wilk","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.tcb.2024.09.001_bb0440","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.it.2020.03.008","article-title":"How neutrophils meet their end","volume":"41","author":"Lawrence","year":"2020","journal-title":"Trends Immunol."},{"key":"10.1016\/j.tcb.2024.09.001_bb0445","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/imr.13153","article-title":"Neutrophils in aging and aging-related pathologies","volume":"314","author":"Van Avondt","year":"2023","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.tcb.2024.09.001_bb0450","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.ccell.2023.02.004","article-title":"Apolipoprotein E induces pathogenic senescent-like myeloid cells in prostate cancer","volume":"41","author":"Bancaro","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tcb.2024.09.001_bb0455","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.cell.2020.06.032","article-title":"Coupled scRNA-seq and intracellular protein activity reveal an immunosuppressive role of TREM2 in cancer","volume":"182","author":"Katzenelenbogen","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.tcb.2024.09.001_bb0460","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.cell.2020.05.003","article-title":"The physiology, pathology, and potential therapeutic applications of the TREM2 signaling pathway","volume":"181","author":"Deczkowska","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.tcb.2024.09.001_bb0465","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/s41419-022-05317-3","article-title":"Senescent neutrophils-derived exosomal piRNA-17560 promotes chemoresistance and EMT of breast cancer via FTO-mediated m6A demethylation","volume":"13","author":"Ou","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.tcb.2024.09.001_bb0470","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/s41568-022-00450-9","article-title":"Exploiting senescence for the treatment of cancer","volume":"22","author":"Wang","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.tcb.2024.09.001_bb0475","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/acel.12445","article-title":"Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors","volume":"15","author":"Zhu","year":"2016","journal-title":"Aging Cell"},{"key":"10.1016\/j.tcb.2024.09.001_bb0480","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nm.4010","article-title":"Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice","volume":"22","author":"Chang","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.tcb.2024.09.001_bb0485","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S1470-2045(10)70261-8","article-title":"Navitoclax, a targeted high-affinity inhibitor of Bcl-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity","volume":"11","author":"Wilson","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.tcb.2024.09.001_bb0490","doi-asserted-by":"crossref","DOI":"10.1093\/oxfimm\/iqad004","article-title":"The ageing immune system as a potential target of senolytics","volume":"4","author":"Du","year":"2023","journal-title":"Oxford Open Immunol."},{"key":"10.1016\/j.tcb.2024.09.001_bb0495","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41586-021-03547-7","article-title":"An aged immune system drives senescence and ageing of solid organs","volume":"594","author":"Yousefzadeh","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.tcb.2024.09.001_bb0500","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.cmet.2021.08.009","article-title":"Senescent immune cells release grancalcin to promote skeletal aging","volume":"33","author":"Li","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.tcb.2024.09.001_bb0505","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41586-022-05388-4","article-title":"Blocking PD-L1\u2013PD-1 improves senescence surveillance and ageing phenotypes","volume":"611","author":"Wang","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.tcb.2024.09.001_bb0510","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/s41573-019-0054-z","article-title":"Neutrophils as emerging therapeutic targets","volume":"19","author":"N\u00e9meth","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tcb.2024.09.001_bb0515","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41575-021-00568-5","article-title":"Neutrophils as potential therapeutic targets in hepatocellular carcinoma","volume":"19","author":"Geh","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.tcb.2024.09.001_bb0520","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002242","article-title":"Neutrophils in the era of immune checkpoint blockade","volume":"9","author":"Faget","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.tcb.2024.09.001_bb0525","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1124\/jpet.114.221358","article-title":"Pharmacological characterization of AZD5069, a slowly reversible CXC chemokine receptor 2 antagonist","volume":"353","author":"Nicholls","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tcb.2024.09.001_bb0530","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.ccell.2016.04.014","article-title":"CXCR2 inhibition profoundly suppresses metastases and augments immunotherapy in pancreatic ductal adenocarcinoma","volume":"29","author":"Steele","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tcb.2024.09.001_bb0535","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1158\/1078-0432.CCR-19-2625","article-title":"Inhibition of MDSC trafficking with SX-682, a CXCR1\/2 inhibitor, enhances NK-cell immunotherapy in head and neck cancer models","volume":"26","author":"Greene","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tcb.2024.09.001_bb0540","doi-asserted-by":"crossref","first-page":"5082","DOI":"10.1200\/JCO.2022.40.16_suppl.5082","article-title":"A randomized Phase Ib\/II study of intermittent androgen deprivation therapy plus nivolumab with or without interleukin-8 blockade in men with hormone-sensitive prostate cancer (MAGIC-8)","volume":"40","author":"Dallos","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tcb.2024.09.001_bb0545","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1200\/JCO.2018.36.15_suppl.3091","article-title":"Phase I trial of BMS-986253, an anti-IL-8 monoclonal antibody, in patients with metastatic or unresectable solid tumors","volume":"36","author":"Collins","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tcb.2024.09.001_bb0550","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.molmed.2023.09.003","article-title":"CXCR2 chemokine receptor \u2013 a master regulator in cancer and physiology","volume":"30","author":"Lazennec","year":"2024","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.tcb.2024.09.001_bb0555","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/s43018-021-00227-3","article-title":"Castration-mediated IL-8 promotes myeloid infiltration and prostate cancer progression","volume":"2","author":"Lopez-Bujanda","year":"2021","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.tcb.2024.09.001_bb0560","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/s41586-023-06696-z","article-title":"Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance","volume":"623","author":"Guo","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.tcb.2024.09.001_bb0565","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10637-023-01410-2","article-title":"CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial","volume":"42","author":"Armstrong","year":"2024","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.tcb.2024.09.001_bb0570","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.1002\/cncr.24597","volume":"115","author":"Bradley","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.tcb.2024.09.001_bb0575","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41598-018-20000-4","article-title":"Small-molecule MDM2 antagonists attenuate the senescence-associated secretory phenotype","volume":"8","author":"Wiley","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tcb.2024.09.001_bb0580","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1038\/s41467-020-16347-w","article-title":"The CD153 vaccine is a senotherapeutic option for preventing the accumulation of senescent T cells in mice","volume":"11","author":"Yoshida","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tcb.2024.09.001_bb0585","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41586-020-2403-9","article-title":"Senolytic CAR T cells reverse senescence-associated pathologies","volume":"583","author":"Amor","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.tcb.2024.09.001_bb0590","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-99852-2","article-title":"Targeted clearance of senescent cells using an antibody\u2013drug conjugate against a specific membrane marker","volume":"11","author":"Poblocka","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tcb.2024.09.001_bb0595","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/imr.13154","article-title":"Human neutrophils \u2260 murine neutrophils: does it matter?","volume":"314","author":"Nauseef","year":"2023","journal-title":"Immunol. Rev."}],"container-title":["Trends in Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0962892424001879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0962892424001879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T20:26:10Z","timestamp":1778790370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0962892424001879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":119,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0962892424001879"],"URL":"https:\/\/doi.org\/10.1016\/j.tcb.2024.09.001","relation":{},"ISSN":["0962-8924"],"issn-type":[{"value":"0962-8924","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Senescent neutrophils: a hidden role in cancer progression","name":"articletitle","label":"Article Title"},{"value":"Trends in Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcb.2024.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}